Answers are grounded in this paper and cite their sources.
The gut microbiota-lung COPD axis was connected. A potentially benefial bacterial strain and its functional component may be developed and used as alternative agents for COPD prevention or treatment.
No takes yet. Share an insight, caveat, or question.
Lai et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: